A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier

BACKGROUND: This study was aimed to prepare a novel magnetic thermosensitive cationic liposome drug carrier for the codelivery of Oxaliplatin (OXA) and antisense lncRNA of MDC1 (MDC1-AS) to Cervical cancer cells and evaluate the efficiency of this drug carrier and its antitumor effects on Cervical c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Nanomedicine
Main Authors: Ye, Hui, Chu, Xiaoying, Cao, Zhensheng, Hu, Xuanxuan, Wang, Zihan, Li, Meiqi, Wan, Leyu, Li, Yongping, Cao, Yongge, Diao, Zhanqiu, Peng, Fengting, Liu, Jinsong, Xu, Lihua
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7886386/
https://ncbi.nlm.nih.gov/pubmed/33603368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S258316
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares